Completed
Topics
This public workshop enabled stakeholders to examine the current state of evidence for drug products used by pregnant and lactating persons, and discussed the barriers and opportunities for including these populations in clinical trials. It provided a foundation for a now completed consensus study on this topic, which was requested by Congress in the Consolidated Appropriations Act, 2022.